Multicenter, Single-Arm Phase II Study of Nab-Paclitaxel/Carboplatin in Untreated PS2 Patients with Advanced NSCLC: TORG1426

被引：0
|
作者：
Naoki, K. [1 ]
Ichikawa, Y. [2 ]
Bessho, A. [3 ]
Hosokawa, S. [3 ]
Shimokawa, T. [4 ]
Yomota, M. [5 ]
Hosomi, Y. [5 ]
Otani, S. [1 ]
Nakahara, Y. [1 ]
Iwasawa, S. [6 ]
Tokito, T. [7 ]
Seki, N. [2 ]
Okamoto, H. [8 ]
机构：
[1] Kitasato Univ, Sch Med, Resp Med, Sagamihara, Kanagawa, Japan
[2] Teikyo Univ, Div Med Oncol, Dept Internal Med, Sch Med, Tokyo, Japan
[3] Japanese Red Cross Okayama Hosp, Resp Med, Okayama, Japan
[4] Yokohama Municipal Citizens Hosp, Yokohama, Kanagawa, Japan
[5] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan
[6] Chiba Univ, Chiba, Japan
[7] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan
[8] Thorac Oncol Res Grp, Yokohama, Kanagawa, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
NSCLC; performance status; nab-Paclitaxel;
D O I：
10.1016/j.jtho.2019.08.730
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-15
引用
收藏
页码：S361 / S361
页数：1
相关论文
共 50 条
  • [21] Interim Results of a Phase I Study of Nivolumab plus Nab-Paclitaxel/Carboplatin in Patients with NSCLC
    Goldman, J. W.
    Waterhouse, D.
    George, B.
    O'Dwyer, P.
    Chen, T.
    Trunova, N.
    Kelly, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1959 - S1960
  • [22] A phase I study of nab-paclitaxel (nP) with carboplatin (C) and thoracic radiation (TRT) in patients with locally advanced NSCLC
    Keedy, V. L.
    Lu, B.
    Horn, L.
    Shyr, Y.
    Winkler, C. F.
    Carbone, D. P.
    Sandler, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [23] PHASE II TRIAL OF NAB-PACLITAXEL PLUS CARBOPLATIN IN PATIENTS WITH ADVANCED NSCLC AT RISK OF BLEEDING FROM VEGF DIRECTED THERAPIES
    Otterson, Gregory A.
    Bertino, Erin M.
    Karim, Nagla A.
    Donthireddy, Kavitha
    Ghany, Ahmed
    Rupert, Robert
    Cantrell, Sarah
    Rahmani, Meliha
    Lynn, Melinda
    Nana-Sinkam, S. P.
    Phillips, Gary S.
    Villalona-Calero, Miguel A.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1288 - S1288
  • [24] Stromal Caveolin-1 Is Associated With Response and Survival in a Phase II Trial of nab-Paclitaxel With Carboplatin for Advanced NSCLC Patients
    Bertino, Erin M.
    Williams, Terence M.
    Nana-Sinkam, S. Patrick
    Shilo, Konstantin
    Chatterjee, Moumita
    Mo, Xiaokui
    Rahmani, Meliha
    Phillips, Gary S.
    Villalona-Calero, Miguel A.
    Otterson, Gregory A.
    CLINICAL LUNG CANCER, 2015, 16 (06) : 466 - +
  • [25] A phase I study of nab-paclitaxel (nab-P) with carboplatin (C) and thoracic radiation (RT) in patients with locally advanced NSCLC.
    Keedy, V. L.
    Lu, B.
    Shyr, Y.
    Horn, L.
    Carbone, D. P.
    Sandler, A.
    Johnson, D. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [26] A phase I/II study of Carboplatin plus Nab-Paclitaxel in PS 2 pts with advanced non-small-cell lung cancer
    Niwa, Takashi
    Nakashima, Kazuhisa
    Yoshioka, Hiroshige
    Iwamoto, Yasuo
    Akamatsu, Hiroaki
    Murakami, Haruyasu
    Mori, Keita
    Takahashi, Toshiaki
    ANNALS OF ONCOLOGY, 2017, 28
  • [27] Camrelizumab plus nab-paclitaxel in platinum-resistant patients with unresectable locally advanced or metastatic urothelial carcinoma: A multicentre, single-arm, phase II study
    Li, H.
    Chen, M.
    Xue, C.
    Li, L.
    Hu, A.
    Yang, W.
    Zheng, Z.
    Ni, M.
    Zhang, L.
    Zeng, Y.
    Peng, J.
    Yao, K.
    Zhou, F.
    Liu, Z.
    An, X.
    Shi, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1335 - S1335
  • [28] Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study
    Jin, Min
    Liu, Hong-Li
    Xue, Jun
    Ma, Hong
    Liu, Jun-Li
    Lin, Zhen-Yu
    Wang, Jing
    Bao, Le-Qun
    Luo, Zhi-Guo
    Yu, Xiong-Jie
    Li, Shuang
    Hu, Jian-Li
    Zhang, Tao
    ONCOLOGIST, 2024, 29 (10): : e1406 - e1418
  • [29] A prospective, single-arm, open-label study of camrelizumab, apatinib and nab-paclitaxel in patients with advanced cervical cancer
    Li, G.
    Zhao, Y.
    Jiang, Y.
    Yang, Q.
    Huang, A.
    Chen, Y.
    Han, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S753 - S754
  • [30] nab-paclitaxel Monotherapy followed by Cetuximab and Radiation in Cisplatin-Unsuitable Patients with Locally Advanced Head and Neck Cancer: A Single-Arm, Multicenter Phase 2 Trial
    Oppelt, P.
    Ley, J.
    Gay, H. A.
    Daly, M. D.
    Jackson, R. S.
    Rich, J.
    Pipkorn, P.
    Paniello, R. C.
    Palka, K.
    Neupane, P.
    Powell, S.
    Spanos, W.
    Gitau, M.
    Liu, J.
    Zevallos, J.
    Thorstad, W. L.
    Adkins, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05): : 1126 - 1126
12345